Current Assets
Inventories
AbbVie Inventories increased by 2.0% to $5.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.6%, from $4.53B to $5.05B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 8.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 8, 2026
How to read this metric
Rising inventory levels may signal anticipated demand growth or, conversely, a buildup of unsold stock; falling levels may indicate strong sales or supply chain constraints.
Detailed definition
This includes the value of raw materials, work-in-progress, and finished pharmaceutical products held by the company. It...
Peer comparison
Highly dependent on manufacturing lead times and product shelf-life; pharmaceutical peers maintain significant inventory to ensure supply continuity.
Metric ID:
inventoriesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.39B | $3.09B | $3.13B | $3.48B | $3.4B | $3.17B | $3.58B | $3.83B | $4.06B | $3.98B | $4.1B | $4.25B | $4.22B | $4.45B | $4.18B | $4.53B | $4.96B | $4.94B | $4.95B | $5.05B |
| QoQ Change | — | -8.6% | +1.1% | +11.3% | -2.5% | -6.6% | +12.8% | +7.1% | +5.8% | -1.8% | +3.0% | +3.6% | -0.6% | +5.5% | -6.0% | +8.3% | +9.6% | -0.4% | +0.3% | +2.0% |
| YoY Change | — | — | — | — | +0.3% | +2.5% | +14.4% | +10.0% | +19.4% | +25.5% | +14.5% | +10.7% | +4.0% | +11.8% | +2.0% | +6.6% | +17.6% | +11.0% | +18.4% | +11.6% |
Range$3.09B – $5.05B
CAGR+8.8%
Avg YoY Growth+11.3%
Median YoY Growth+11.3%
Current Streak2 quarters growth
Inventories at Other Companies
Frequently Asked Questions
- What is AbbVie's inventories?
- AbbVie (ABBV) reported inventories of $5.05B in Q1 2026.
- How has AbbVie's inventories changed year-over-year?
- AbbVie's inventories increased by 11.6% year-over-year, from $4.53B to $5.05B.
- What is the long-term trend for AbbVie's inventories?
- Over 5 years (2020 to 2025), AbbVie's inventories has grown at a 8.4% compound annual growth rate (CAGR), from $3.31B to $4.95B.
- What does inventories mean?
- The total value of all products and materials the company has in stock.